SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-048256
Filing Date
2021-09-15
Accepted
2021-09-15 16:49:33
Documents
14
Period of Report
2021-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147489-8k_celularity.htm   iXBRL 8-K 59468
2 EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND DR. ANDREW PECORA, DATED AS ea147489ex10-1_celularityinc.htm EX-10.1 83216
  Complete submission text file 0001213900-21-048256.txt   396487

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE celu-20210909_def.xml EX-101.DEF 27888
4 XBRL LABEL FILE celu-20210909_lab.xml EX-101.LAB 37124
5 XBRL PRESENTATION FILE celu-20210909_pre.xml EX-101.PRE 26506
6 XBRL SCHEMA FILE celu-20210909.xsd EX-101.SCH 3874
7 EXTRACTED XBRL INSTANCE DOCUMENT ea147489-8k_celularity_htm.xml XML 5755
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 211255845
SIC: 2834 Pharmaceutical Preparations